Literature DB >> 1581555

Uptake, distribution and fate of bacterial lipopolysaccharides in monocytes and macrophages: an ultrastructural and functional correlation.

Y H Kang1, C H Lee, R L Monroy, R S Dwivedi, C Odeyale, H H Newball.   

Abstract

Bacterial lipopolysaccharides (LPS), which are important components of the cell wall of gram-negative bacteria, induce a number of host responses both beneficial and harmful. The present review elucidates the uptake, distribution and functions of LPS in mononuclear phagocytes in an attempt to gain an insight into the mechanisms which control the pathogenesis of LPS mediated septic shock. The unique feature of LPS bilayer structure, the tagged LPS and antibodies to LPS provide means for studying binding, uptake, fate and subcellular distribution of LPS in tissues and cells. LPS bind to monocytes and macrophages by specific interaction via receptors such as scavenger receptors, CD14 and CD18 and by non-specific interactions, and enter the cells via receptor-mediated endocytosis, absorptive pinocytosis, phagocytosis, and diffusion. The ingested LPS are localized in pinocytic vesicles, phagocytic vacuoles, cytoplasm, mitochondria, rough endoplasmic reticulum, Golgi apparatus, and nucleus. The interactions of LPS with monocytes and macrophages trigger a broad spectrum of cellular responses, including production of important bioactive factors or mediators, such as IL-1, TNF, interferons, prostaglandins, and macrophage-derived growth factor, which are implicated in the pathogenesis of septic shock and wound healing. However, there is no conclusive evidence indicating that production of the mediators can only be induced through specific interactions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1581555     DOI: 10.1016/0892-0354(92)90016-j

Source DB:  PubMed          Journal:  Electron Microsc Rev        ISSN: 0892-0354


  8 in total

1.  Endotoxin binding and elimination by monocytes: secretion of soluble CD14 represents an inducible mechanism counteracting reduced expression of membrane CD14 in patients with sepsis and in a patient with paroxysmal nocturnal hemoglobinuria.

Authors:  N Hiki; D Berger; C Prigl; E Boelke; H Wiedeck; M Seidelmann; L Staib; M Kaminishi; T Oohara; H G Beger
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

2.  The role of cerebral vascular NFkappaB in LPS-induced inflammation: differential regulation of efflux transporter and transporting cytokine receptors.

Authors:  Weihong Pan; Chuanhui Yu; Hung Hsuchou; Abba J Kastin
Journal:  Cell Physiol Biochem       Date:  2010-05-18

3.  Yersinia lipopolysaccharide is modified by human monocytes.

Authors:  M Wuorela; S Jalkanen; P Toivanen; K Granfors
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

4.  Lipopolysaccharide inhibits the channel activity of the P2X7 receptor.

Authors:  Elias Leiva-Salcedo; Claudio Coddou; Felipe E Rodríguez; Antonello Penna; Ximena Lopez; Tanya Neira; Ricardo Fernández; Mónica Imarai; Miguel Rios; Jorge Escobar; Margarita Montoya; J Pablo Huidobro-Toro; Alejandro Escobar; Claudio Acuña-Castillo
Journal:  Mediators Inflamm       Date:  2011-09-14       Impact factor: 4.711

5.  Transport of bacterial lipopolysaccharide to the golgi apparatus.

Authors:  N Thieblemont; S D Wright
Journal:  J Exp Med       Date:  1999-08-16       Impact factor: 14.307

6.  The role of intestinal endotoxemia in a rat model of aluminum neurotoxicity.

Authors:  Feng Wang; Rui-Xia Guo; Wen-Xing Li; Bao-Feng Yu; Bai Han; Li-Xin Liu; De-Wu Han
Journal:  Mol Med Rep       Date:  2017-06-15       Impact factor: 2.952

7.  Macrolets: Outsized Extracellular Vesicles Released from Lipopolysaccharide-Stimulated Macrophages that Trap and Kill Escherichia coli.

Authors:  Wei Ding; Olivia C Rivera; Shannon L Kelleher; David I Soybel
Journal:  iScience       Date:  2020-05-05

8.  Ultrastructural Comparison of the Nasal Epithelia of Healthy and Naturally Affected Rabbits with Pasteurella multocida A.

Authors:  Paula Esquinas; Lucía Botero; María Del Pilar Patiño; Carolina Gallego; Carlos Iregui
Journal:  Vet Med Int       Date:  2013-03-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.